Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Roche’s new deals head tries to navigate a more ‘complicated’ and ‘expensive’ biotech world
BioPharma Dive
Thursday, January 16, 2025 - 9:52pm
tags:
Roche, Boris Zaitra
CMS faces renewed legal pressure on drug price negotiation program
Fierce Healthcare
Thursday, January 16, 2025 - 9:44pm
tags:
Teva Pharmaceutical, CMS, drug pricing, Inflation Reduction Act
How Bayer cracked the retail media code
Medical Marketing and Media
Thursday, January 16, 2025 - 9:40pm
tags:
Bayer, pharma ads, Skai, DTC advertising
Boehringer's phase 3 schizophrenia program misses primary goal
Fierce Biotech
Thursday, January 16, 2025 - 9:39pm
tags:
Boehringer Ingelheim, schizophrenia, clinical trials, iclepertin
The Rise of China Innovation in the Time of Trump
BioSpace
Thursday, January 16, 2025 - 11:22am
tags:
China, innovation, Donald Trump, trade
After Letter to Commissioner, FDA Finally Gives Vanda Reason for Rejection, Chance for Hearing
BioSpace
Thursday, January 16, 2025 - 11:21am
tags:
FDA, Robert Califf, Vanda Pharmaceuticals, tradipitant
JPM25: Emergent secures licensing deal for opioid overdose spray amid recovery plan
Fierce Pharma
Thursday, January 16, 2025 - 11:17am
tags:
JPMHC 2025, Emergent BioSolutions, opioid overdose, Kloxxado, Narcan
JPM25: Bayer gears up for 'must-win battles' as Xarelto's decline is in full swing, pharma chief says
Fierce Pharma
Thursday, January 16, 2025 - 11:16am
tags:
Bayer, Xarelto, JPMHC 2025
Qiagen Receives FDA Clearance for First Mini Gastrointestinal Panel
Xtalks
Thursday, January 16, 2025 - 11:15am
tags:
Qiagen, Medtech, diagnostics, FDA, gastrointestinal disease
Google Cloud 'can't wait to see what's next' as Servier extends AI drug R&D pact
Fierce Biotech
Thursday, January 16, 2025 - 11:13am
tags:
Servier, Google Cloud, artificial intelligence
Sanofi to increase competition in atopic dermatitis market after Dupixent success
Clinical Trials Arena
Thursday, January 16, 2025 - 11:09am
tags:
Sanofi, KT-474, Kymera Therapeutics, atopic dermatitis, Dupixent
Gilead settles with US government in long-running patent dust-up over PrEP meds Truvada, Descovy
Fierce Pharma
Thursday, January 16, 2025 - 11:08am
tags:
Gilead Sciences, DOJ, HHS, patents, Truvada, Descovy, legal
OS Therapies’s HER2 therapy prevents lung cancer recurrence in 33% patients
Clinical Trials Arena
Thursday, January 16, 2025 - 11:06am
tags:
OS Therapies, lung cancer, HER2 Inhibitor
By the numbers: J&J, GSK lead J.P. Morgan deal announcements in 2025, the largest turnout in years
Pharma Voice
Thursday, January 16, 2025 - 11:02am
tags:
JPMHC 2025, M&A, JNJ, Intra-Cellular Therapeutics, GSK, IDRx
Biopharma’s AI rally: Readiness not hype in 2025
Pharmaphorum
Thursday, January 16, 2025 - 11:01am
tags:
biotech, artificial intelligence
Micron Biomedical Extends Series A Financing to 33+ Million to Accelerate Commercialization of Needle-Free Therapeutics and Vaccines
Yahoo Finance
Thursday, January 16, 2025 - 11:00am
tags:
Micron Biomedical, needle-free vaccines, vaccines, funding
JP Morgan 2025: AbbVie counts on Skyrizi and Rinvoq to fill Humira-sized hole
Clinical Trials Arena
Wednesday, January 15, 2025 - 11:54pm
tags:
JPMHC 2025, AbbVie, Skyrizi, Rinvoq, Humira
JPM25: Takeda spotlights 6 pipeline assets that could pull down up to $20B in collective peak sales
Fierce Pharma
Wednesday, January 15, 2025 - 11:52pm
tags:
Takeda, JPMHC 2025
Lilly's Omvoh scores second IBD win with FDA nod in Crohn's
First Word Pharma
Wednesday, January 15, 2025 - 11:50pm
tags:
Eli Lilly, Omvoh, IBD, FDA, Crohn's Disease
Federal watchdog cites concerns with FDA’s accelerated approval process
BioPharma Dive
Wednesday, January 15, 2025 - 11:48pm
tags:
HHS, FDA, accelerated approvals, Aduhelm, Biogen

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.